These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37487481)

  • 1. A Meta-Analysis of Neurodevelopmental Outcomes following Intravitreal Bevacizumab for the Treatment of Retinopathy of Prematurity.
    Baiad AA; Kherani IZ; Popovic MM; Katsnelson G; Muni RH; Mireskandari K; Tehrani NN; Zhou TE; Kertes PJ
    Neonatology; 2023; 120(5):577-588. PubMed ID: 37487481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental Outcomes after Bevacizumab Treatment for Retinopathy of Prematurity: A Meta-analysis.
    Tsai CY; Yeh PT; Tsao PN; Chung YE; Chang YS; Lai TT
    Ophthalmology; 2021 Jun; 128(6):877-888. PubMed ID: 33212122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab and neurodevelopmental outcomes of preterm infants with retinopathy of prematurity: should we still worry?
    Celik P; Ayranci Sucakli I; Kara C; Petricli IS; Kavurt S; Celik IH; Bas AY; Demirel N
    J Matern Fetal Neonatal Med; 2022 Feb; 35(3):415-422. PubMed ID: 33618591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Chandra P
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity.
    Arima M; Akiyama M; Fujiwara K; Mori Y; Inoue H; Seki E; Nakama T; Tsukamoto S; Ochiai M; Ohga S; Sonoda KH
    PLoS One; 2020; 15(3):e0230678. PubMed ID: 32196539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.
    Gunay M; Sukgen EA; Celik G; Kocluk Y
    Curr Eye Res; 2017 Mar; 42(3):462-469. PubMed ID: 27420302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental outcomes in infants treated with intravitreal bevacizumab versus laser.
    Raghuram K; Isaac M; Yang J; AlAli A; Mireskandari K; Ly LG; Kelly E; Banihani R; Shah PS; Tehrani N
    J Perinatol; 2019 Sep; 39(9):1300-1308. PubMed ID: 31341226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP.
    Rodriguez SH; Peyton C; Lewis K; Andrews B; Greenwald MJ; Schreiber MD; Msall ME; Blair MP
    Ophthalmic Surg Lasers Imaging Retina; 2019 Jun; 50(6):337-343. PubMed ID: 31233150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab for Retinopathy of Prematurity: 2-Year Neurodevelopmental Follow-up.
    Zayek M; Parker K; Rydzewska M; Rifai A; Bhat R; Eyal F
    Am J Perinatol; 2021 Sep; 38(11):1158-1166. PubMed ID: 32446264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment.
    Lien R; Yu MH; Hsu KH; Liao PJ; Chen YP; Lai CC; Wu WC
    PLoS One; 2016; 11(1):e0148019. PubMed ID: 26815000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity.
    Morin J; Luu TM; Superstein R; Ospina LH; Lefebvre F; Simard MN; Shah V; Shah PS; Kelly EN;
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 27244705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective clinical study of two different treatment regimens of combined laser photocoagulation and intravitreal bevacizumab for retinopathy of prematurity: the Indian Twin Cities ROP Study (ITCROPS) database report number 9.
    Laveti V; Balakrishnan D; Rani PK; Mohamed A; Jalali S
    Int Ophthalmol; 2020 Dec; 40(12):3539-3545. PubMed ID: 32776299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity.
    Akdogan M; Cevik SG; Sahin O
    Indian J Ophthalmol; 2019 Jun; 67(6):879-883. PubMed ID: 31124508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary anatomical and neurodevelopmental outcomes of intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity.
    Araz-Ersan B; Kir N; Tuncer S; Aydinoglu-Candan O; Yildiz-Inec D; Akdogan B; Ekici B; Demirel A; Ozmen M
    Curr Eye Res; 2015 May; 40(6):585-91. PubMed ID: 25025864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis.
    Kaushal M; Razak A; Patel W; Pullattayil AK; Kaushal A
    J Perinatol; 2021 Jun; 41(6):1225-1235. PubMed ID: 33293666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental Outcomes after Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity: A Prospective Case-Control Study.
    Fan YY; Huang YS; Huang CY; Hsu JF; Shih CP; Hwang YS; Yao TC; Lai CC; Wu WC
    Ophthalmology; 2019 Nov; 126(11):1567-1577. PubMed ID: 30954553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year refractive outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity.
    Kıran Yenice E; Petriçli İS; Kara C
    Int Ophthalmol; 2023 Jul; 43(7):2197-2202. PubMed ID: 36522564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental Outcomes for Retinopathy of Prematurity: A Taiwan Premature Infant Follow-up Network Database Study.
    Chiang MC; Chen YT; Kang EY; Chen KJ; Wang NK; Liu L; Chen YP; Hwang YS; Lai CC; Wu WC
    Am J Ophthalmol; 2023 Mar; 247():170-180. PubMed ID: 36343698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of intravitreal bevacizumab for the treatment of retinopathy of prematurity: a single-center retrospective review.
    Frosini S; Franco F; Vicini G; Nicolosi C; Varriale G; Dani C; Virgili G; Giansanti F
    J Matern Fetal Neonatal Med; 2022 Sep; 35(17):3337-3342. PubMed ID: 32933350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.